Markets:

Overview

News

Currencies

International

Treasuries

AbCellera Biologics Inc. - Common Shares (NQ:ABCL)

3.620 -0.120 (-3.21%)

Streaming Delayed Price Updated: 4:00 PM EST, Dec 12, 2025 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about AbCellera Biologics Inc. - Common Shares

< Previous 1 2

...

4 5 6 7 8 9 10 11 Next >

The Daily Biotech Pulse: Moderna To Join S&P 500 Index, Thumbs Down For FibroGen's Anemia Drug, Corvus Shelves COVID Study ↗

July 16, 2021

Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs July 15) IVERIC bio, Inc. (NASDAQ:...

Via Benzinga

Topics Stocks

The Daily Biotech Pulse: Galapagos Sinks On Data, J&J Recalls Sunscreen Products, FibroGen Awaits AdCom Verdict, 3 IPOs ↗

July 15, 2021

Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs July 14) Alexion Pharmaceuticals,...

Via Benzinga

Topics Product Recall

Stocks That Hit 52-Week Lows On Wednesday ↗

July 14, 2021

Wednesday morning saw 57 companies set new 52-week lows. Noteworthy Points: Campbell Soup (NYSE:CPB) was the largest firm by market cap to set a new 52-week low....

Via Benzinga

AbCellera Appoints Neil Berkley as Chief Business Officer

July 13, 2021

From AbCellera Biologics Inc.

Via Business Wire

The Daily Biotech Pulse: ScPharma's Positive Data, Lilly Goes Shopping, LeMaitre Pre-Announces Q2 Revenues ↗

July 14, 2021

Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs July 13) Biohaven Pharmaceutical...

Via Benzinga

Wednesday Is A Normal Day ↗

June 23, 2021

Meme stocks Gamestop and Torchlight Energy both did share sales to cash in on their share price rises.

Via Talk Markets

The Daily Biotech Pulse: Lilly, Morphic's Positive Data At ECCO, Humanigen's COVID Treatment Gets Expedited Review In UK, TransCode IPO ↗

July 09, 2021

Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs July 8) Aerpio Pharmaceuticals, Inc...

Via Benzinga

The Daily Biotech Pulse: Priority Review For Amgen's Asthma Treatment, Evaxion Reports Positive Skin Cancer Readout, Quidel Recalls Lyra COVID-19 Test ↗

July 08, 2021

Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs July 7) Ambrx Biopharma Inc. (NYSE:...

Via Benzinga

Topics Product Recall

Stocks That Hit 52-Week Lows On Wednesday ↗

July 07, 2021

Before 10 a.m. ET on Wednesday, 49 companies set new 52-week lows. Noteworthy Highlights: The largest company in terms of market cap to set a new 52-week low was China...

Via Benzinga

Stocks That Hit 52-Week Lows On Wednesday ↗

June 23, 2021

Wednesday morning, 7 companies reached new 52-week lows. Interesting Points: AbCellera Biologics (NASDAQ:ABCL) was the largest firm by market cap to set a new 52-...

Via Benzinga

26 Stocks Moving in Wednesday's Pre-Market Session ↗

June 23, 2021

Gainers Acasti Pharma Inc. (NASDAQ: ACST) rose 39% to $0.75 in pre-market trading after jumping 10% on Tuesday. The company reported a narrower FY21 loss. SeaChange International...

Via Benzinga

The Daily Biotech Pulse: Opiant Spikes On Data, OncoSec Rallies On Merck Collaboration, XBiotech Special Dividend ↗

July 07, 2021

Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs July 6) Ambrx Biopharma Inc. (NYSE:...

Via Benzinga

AbCellera Continues Expansion and Strengthens Future Pandemic Preparedness with First-of- its-Kind GMP Manufacturing Facility for Therapeutic Antibodies in Canada

June 22, 2021

From AbCellera Biologics Inc.

Via Business Wire

The Daily Biotech Pulse: Lilly Spikes On Alzheimer's Drug Regulatory Filing Plan, Applied Genetics, Arcus Issue Data Readouts, Adcom Test Awaits Incyte, Monte Rosa Prices IPO ↗

June 24, 2021

Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs June 23) AngioDynamics, Inc. (NASDAQ...

Via Benzinga

Stocks That Hit 52-Week Lows On Monday ↗

June 21, 2021

During Monday's morning session, 22 companies made new 52-week lows. Key Facts: China Life Insurance Co (NYSE:LFC) was the largest, in terms of market cap, to...

Via Benzinga

The Daily Biotech Pulse: Sanofi, Translate Bio Start Early Stage Seasonal Flu Vaccine Study, Dr. Reddy's Launches Generic Vascepa, Halozyme Strikes Licensing Deal ↗

June 22, 2021

Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs June 21) Agios Pharmaceuticals, Inc...

Via Benzinga

The Daily Biotech Pulse: Orphazyme Falters At FDA, Athira's CEO Placed On Temporary Leave, 5 IPOs ↗

June 18, 2021

Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs June 17) 10x Genomics, Inc. (NASDAQ...

Via Benzinga

Stocks That Hit 52-Week Lows On Thursday ↗

June 17, 2021

Before 10 a.m. ET on Thursday, 16 companies hit new 52-week lows. Areas of Interest: Vertex Pharmaceuticals (NASDAQ:VRTX) was the biggest company by market cap to...

Via Benzinga

The Daily Biotech Pulse: Biogen Faces Another Clinical Setback, CureVac's COVID-19 Vaccine Study Fails, Moment Of Reckoning For Orphazyme ↗

June 17, 2021

Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs June 16) Alexion Pharmaceuticals,...

Via Benzinga

Dreary Day ↗

June 14, 2021

Another dreary day and a renewed boost for cryptocurrency - and away from the classic inflation hedge, gold.

Via Talk Markets

Happy Friday ↗

June 11, 2021

The inflation risk is being ignored by the US market now that there will probably not be a tax increase and may be higher prices for longer.

Via Talk Markets

AbCellera Announces Secondary Private Sale of 11.9 Million Common Shares

June 10, 2021

From AbCellera Biologics Inc.

Via Business Wire

The Daily Biotech Pulse: US To Procure 500M Pfizer-BioNTech Vaccine Doses For Donation, Verona Out-Licenses COPD Drug, Nautilus Lists Through SPAC Deal ↗

June 10, 2021

Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs June 9) Aethlon Medical, Inc. (...

Via Benzinga

New New Deal Worries ↗

May 27, 2021

Nio is up 1.4% today on another round of Meme buying.

Via Talk Markets

The Surprising Move Vir Stock Made After Winning Covid Drug Authorization ↗

May 27, 2021

GlaxoSmithKline and Vir Biotechnology won Food and Drug Administration authorization for a Covid treatment on Wednesday, but Vir stock slipped Thursday.

Via Investor's Business Daily

Sterling At Five-Year High ↗

May 25, 2021

Today markets are mixed because of currency factors, with sterling bullishness against the dollar and the euro.

Via Talk Markets

60 Biggest Movers From Yesterday ↗

May 27, 2021

Gainers Lizhi Inc. (NASDAQ: LIZI) shares surged 57.6% to close at $6.84 on Wednesday. Flywire Corporation (NASDAQ: FLYW) gained 46.3% to settle at $35.10 after the company priced...

Via Benzinga

Worldwide Upbeat ↗

May 21, 2021

The US crackdown on cryptocurrencies continues with the Fed today indicating that an official crypto-currency is going to be created for the USA.

Via Talk Markets

Topics Economy

Another Tough Day For Markets ↗

May 17, 2021

The stock market resumed its negativism today mainly linked to fear of inflation and higher interest rates, on the argument that the most dangerous thing to believe is “it's different this time.”

Via Talk Markets

CORRECTING and REPLACING AbCellera Reports Q1 2021 Business Results

May 14, 2021

From AbCellera Biologics Inc.

Via Business Wire

< Previous 1 2

...

4 5 6 7 8 9 10 11 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.

AbCellera Biologics Inc. - Common Shares (NQ:ABCL)

All News about AbCellera Biologics Inc. - Common Shares

Starting at $3.75/week.

Subscribe Today